📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Study design approaches for future active-controlled HIV prevention trials. (2024)

First Author: Donnell D

Attributed to: A combination efficacy study in Africa of two DNA-MVA- or DNA- Env protein HIV-1 vaccine regimens with pre-exposure prophylaxis (PrEP) – supplementary funding for MPLA-Liposomes funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1515/scid-2023-0002

PubMed Identifier: 38250627

Publication URI: http://europepmc.org/abstract/MED/38250627

Type: Journal Article/Review

Volume: 15

Parent Publication: Statistical communications in infectious diseases

Issue: 1

ISSN: 1948-4690